STUDI PENGGUNAAN OBAT ANTI TUBERKULOSIS (OAT) KATEGORI 1 TERHADAP PASIEN TUBERKULOSIS PARU TAHAP LANJUTAN (Penelitian Dilakukan di Rumah Sakit Umum Daerah dr.Mohammad Zyn Sampang)
Daftar Isi:
- Background: Tuberculosis is the second most common cause of death after HIV, and emerged as a major public health problem today. Tuberculosis is caused by infection with dissemination mycrobacterium tuberculosis primarily through the air. Objective : The study is to determine the pattern of therapy and the use of anti-tuberculosis drug in patients with pulmonary tuberculosis in first category continued phase. Research methods: The study was observational, descriptive, and retrospectively by processing the patient medical record. The total population is 140 people, with a sample of 20 people. Results and conclusions: Patterns of use anti-tuberculosis first category continued phase in 20 patients is given in 2 Type anti-tuberculosis, ie anti-tuberculosis separated and anti-tuberculosis FDC. Patients with anti-tuberculosis FDC usage patterns as many as 3 people (15%), and the use of anti-tuberculosis separated as many as 17 people (85%). The use of anti-tuberculosis FDC used is 1x2 tablet 2FDC 4(H3R3) of 1 person (33%) and 1x3 tablet 2FDC 4(H3R3) for 2 people (67%). The use of anti-tuberculosis separated as many as 17 people (100%) with the dose administered Rifampin = 450mg / 300mg Isoniazid = 4 (H3R3). The use of anti-tuberculosis in combination with other antibiotics at 1 (100%) is 1x3 tablet 2FDC 4 (H3R3) + Cefadroxil (2 x 500 mg) PO. The pattern of the highest switching therapy in the study include anti-tuberculosis FDC be anti-tuberculosis separated in 2 (67%). The use of anti-tuberculosis in dr.Mohammad Zyn Sampang hospitals are in accordance with the guidelines. Keywords: Anti-Tuberculosis, Tuberculosis Pulmonary, Continued Phase